Dr. Eric Leuthardt is not just advancing neuroscience; he’s redefining it. A pioneering neurosurgeon, scientist, and entrepreneur, he turns groundbreaking research into life-changing solutions for patients, launches companies that drive economic growth, and rallies a city to imagine what’s possible when science is guided by purpose. From the operating room to the boardroom, his work in St. Louis proves that innovation matters most when it changes lives.
From Trouble to Transformation
Born in Boston, Eric spent part of his childhood in Germany before settling in Cincinnati. His journey toward becoming a leader in neurotechnology began with an unexpected twist. As a high school student prone to trouble, his mother signed him up to work in a surgical research lab. That decision proved life-changing. Under the mentorship of neurosurgeon Keith Crutcher, whose approach blended science, theology, and philosophy, Eric discovered both a passion for surgery and a fascination with the deeper meaning of scientific work.
The Theology of Innovation
A scholarship brought him to Saint Louis University, where he earned degrees in biology and theology. The latter, he says, shaped his thinking even more than science, giving him a framework for asking why work matters, not just how it’s done. After earning his medical degree from the University of Pennsylvania, he returned to St. Louis for a neurosurgery residency at Washington University, followed by advanced fellowships in epilepsy and spine surgery.
From Lab Breakthroughs to Real-World Impact
From the start, Eric pursued science with a clear goal: impact in the real world. Working with engineer Dan Moran, he helped develop the first FDA-approved brain-computer interface, enabling patients to control devices—and later, paralyzed limbs—simply by thinking. The company is called Neurolutions. Now FDA-approved, the technology reflects his belief that research must move beyond journals to create tangible solutions that improve lives.
Leading the Next Wave of Neurotechnology
Today, Eric is Professor of Neurosurgery, Biomedical Engineering, and Mechanical Engineering at Washington University. He serves as Vice Chair of Innovation, Director of the Division of Neurotechnology, and Assistant Vice Chancellor for Innovation and Commercialization. His entrepreneurial ventures span brain-computer interfaces, AI-powered brain mapping, and minimally invasive diagnostics. Each shares the same principle: breakthroughs must be engineered into accessible, self-sustaining solutions that help people directly. His pursuit of this vision even led him to earn a Master’s in Business Administration.
“My personal North Star is that we must have an impact on people’s lives and society. To do that, you must move through the full arc, from discovery to delivery.”
Partnering with BioSTL to Build a Neurotech Ecosystem
Eric’s impact extends beyond the lab and his own companies through his collaboration with BioSTL. Together with Eric Gulve, Founding Chief Executive Officer (CEO) & Principal Investigator for NEURO360, he co-led the Neuro360 initiative, a National Science Foundation–funded effort to assemble a St. Louis–wide neurotechnology network and economic engine. Eric’s own companies have also benefitted directly from BioGenerator, BioSTL’s startup arm, with seed investment to grow the ideas. Neurolutions’ IpsiHand technology, which restores movement for stroke survivors, received FDA Breakthrough Designation and clearance, and has now entered the market with strong demand. BioGenerator also provided early support for his latest venture, Aurenar, a neurotechnology startup aiming to transform intensive care units by reducing life-threatening complications from inflammation. For Eric, the partnership has been pivotal: “BioGenerator has been a superb partner in growing my companies personally and an essential partner in building the neurotechnology ecosystem regionally. They are an essential growth driver in St. Louis.”
Betting on St. Louis
Eric is a steadfast champion of St. Louis as a global innovation hub. He sees the region’s world-class research institutions, collaborative culture, and high quality of life as fertile ground for breakthroughs in neuroscience and technology. Whether in the lab, clinic, boardroom, or on stage as a playwright and neuro-focused brain-computer interface (BCI) science fiction novelist, he works to inspire others to think boldly about the future—and their role in shaping it.
Impact as the True Measure of Success
For Eric, success is measured by meaningful impact even beyond patient care. From restoring movement to stroke survivors to building companies that create jobs and economic opportunity, his North Star remains constant: science and innovation are only complete when they touch the human experience.